Search Result "GLP1 RA."


Glucagon-Like Peptide 1 and the Cardiovascular System

Journal: Current Diabetes Reviews
Volume: 10 Issue: 5 Year: 2014 Page: 302-310
Author(s): Stephen Fava

Research Article

Sodium Glucose Cotransporter-2 Inhibitor Treatment and the Risk of Diabetic Ketoacidosis in Denmark: A Retrospective Cohort Study of Five Years of Use

Journal: Current Drug Safety
Volume: 16 Issue: 1 Year: 2021 Page: 73-81
Author(s): Henrik V.B. Laursen,Johan B. Røikjer,Jakob Dal,Morten Hasselstrøm Jensen

Perspective

Redefining Cardiovascular (CV) Death as a Primary Endpoint Component in Cardiovascular Outcome Trials

Journal: Current Diabetes Reviews
Volume: 16 Issue: 9 Year: 2020 Page: 917-921
Author(s): Samit Ghosal,Binayak Sinha

Review Article

The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?

Journal: Current Vascular Pharmacology
Volume: 16 Issue: 3 Year: 2018 Page: 254-268
Author(s): Marianna Papademetriou,Vasilios G. Athyros,Eleni Geladari,Michael Doumas,Costas Tsioufis,Vasilios Papademetriou

Review Article

Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints

Journal: Current Pharmaceutical Design
Volume: 24 Issue: 17 Year: 2018 Page: 1879-1886
Author(s): Michael Doumas,Κonstantinos Imprialos,Konstantinos Stavropoulos,Andromachi Reklou,Alexandros Sachinidis,Vasilios G. Athyros

Review Article

Glucagon-like Peptide-1 Receptor Agonists Cardio-protective Effects: An Umbrella Review

Journal: Current Diabetes Reviews
Volume: 16 Issue: 8 Year: 2020 Page: 820-832
Author(s): Asim Ahmed Elnour,Noora Al Hajri,Israa Yousif El Khidir,Abdulla AlAmoodi,Sahar Asim Ahmed,Adel Sadeq

Perspectives in vascular pharmacology

What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?

Journal: Current Vascular Pharmacology
Volume: 17 Issue: 5 Year: 2019 Page: 425-428
Author(s): Michael Doumas,Konstantinos Imprialos,Konstantinos Stavropoulos,Vasilios G. Athyros

Review Article

GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus

Journal: Current Diabetes Reviews
Volume: 16 Issue: 4 Year: 2020 Page: 279-292
Author(s): Lalita Dahiya,Ramandeep Kaur,Rajiv Kumar,Manoj Kumar,Kezia Palta

Diabetes Therapy: Novel Patents Targeting the Glucose-Induced Insulin Secretion

Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 4 Issue: 1 Year: 2010 Page: 1-9
Author(s): Sergio Polakof

Editorial free to download

Editorial: Do Some Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1 RA) Reduce Macrovascular Complications of Type 2 Diabetes Mellitus? (A Commentary on the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) Trial)

Journal: Current Vascular Pharmacology
Volume: 14 Issue: 5 Year: 2016 Page: 469-473
Author(s): Vasilios G. Athyros, Niki Katsiki, Nikolaos Tentolouris

Previous   Next

Go To   Results 1 - 1 of 105

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy